Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gutman

Showing results (451-460 of 500) with videos related to

Pageof 50
Sort By:
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
American Journal of Hematology|February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid LeukemiaMichael K Jones, Jesse Sanchez, Megan Connor, et al.
BMC Medical Genomics|June 4, 2014
Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group projectRivka R Colen, Mark Vangel, Jixin Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 20, 2015
De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissueKathleen M Gavin, Jonathan A Gutman, Wendy M Kohrt, et al.
IEEE Transactions on Bio-Medical Engineering|July 27, 2010
An integrative approach for in silico glioma researchLee A D Cooper, Jun Kong, David A Gutman, et al.
Eclinicalmedicine|October 27, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trialDaniel A Pollyea, Brett M Stevens, Diana Abbott, et al.
Brain Imaging and Behavior|March 23, 2018
Subcortical shape and neuropsychological function among U.S. service members with mild traumatic brain injuryDavid F Tate, Benjamin S C Wade, Carmen S Velez, et al.
Neuroimage. Clinical|April 28, 2019
Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIVBenjamin S C Wade, Victor G Valcour, Thanyawee Puthanakit, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
Pageof 50

Showing results (451-460 of 500) with videos related to

Sort By:
Pageof 50
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
American Journal of Hematology|February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid LeukemiaMichael K Jones, Jesse Sanchez, Megan Connor, et al.
BMC Medical Genomics|June 4, 2014
Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group projectRivka R Colen, Mark Vangel, Jixin Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 20, 2015
De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissueKathleen M Gavin, Jonathan A Gutman, Wendy M Kohrt, et al.
IEEE Transactions on Bio-Medical Engineering|July 27, 2010
An integrative approach for in silico glioma researchLee A D Cooper, Jun Kong, David A Gutman, et al.
Eclinicalmedicine|October 27, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trialDaniel A Pollyea, Brett M Stevens, Diana Abbott, et al.
Brain Imaging and Behavior|March 23, 2018
Subcortical shape and neuropsychological function among U.S. service members with mild traumatic brain injuryDavid F Tate, Benjamin S C Wade, Carmen S Velez, et al.
Neuroimage. Clinical|April 28, 2019
Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIVBenjamin S C Wade, Victor G Valcour, Thanyawee Puthanakit, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
Pageof 50